VA
VR Adviser Portfolio holdings
AUM
$2.02B
1-Year Est. Return
169.23%
This Fund
S&P 500
1 Year Est. Return
+169.23%
AUM
$2.02B
AUM Growth
+$248M
(+14%)
Holding
34
Top Buys
| 1 | +$26.9M | |
| 2 | +$26.1M | |
| 3 | +$24.7M | |
| 4 |
MAZE
Maze Therapeutics
MAZE
|
+$10.9M |
| 5 |
CBIO
Crescent Biopharma
CBIO
|
+$9.5M |
Top Sells
| 1 | +$196M | |
| 2 | +$90.7M | |
| 3 | +$71M | |
| 4 |
Cogent Biosciences
COGT
|
+$56.2M |
| 5 |
ABVX
Abivax
ABVX
|
+$49M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apogee Therapeutics
APGE
$4.99B
| $641M | 31.67% |
8,493,321
|
|
||
|
ORKA
2
Oruka Therapeutics
ORKA
$1.6B
| $126M | 6.21% |
4,148,428
|
|
||
3
Viridian Therapeutics
VRDN
$2.9B
| $121M | 5.97% |
3,882,709
|
|
||
4
Spyre Therapeutics
SYRE
$3.15B
| $121M | 5.96% |
3,685,448
+1,000,000
|
|
||
5
KalVista Pharmaceuticals
KALV
$820M
| $109M | 5.37% |
6,728,985
|
|
||
6
Ocular Therapeutix
OCUL
$2.24B
| $88.8M | 4.39% |
7,315,547
-5,845,915
|
|
||
7
Savara
SVRA
$1.07B
| $82.9M | 4.09% |
13,740,375
+1,059,332
|
|
||
|
8
Cogent Biosciences
COGT
$6.02B
| $71M | 3.51% |
2,000,000
-2,000,000
|
|
||
9
Erasca
ERAS
$4.79B
| $66.4M | 3.28% |
17,857,083
|
|
||
10
CytomX Therapeutics
CTMX
$793M
| $66.3M | 3.27% |
15,561,500
|
|
||
|
MAZE
11
Maze Therapeutics
MAZE
$2.16B
| $64.2M | 3.17% |
1,548,569
+317,800
|
|
||
|
JBIO
12
Jade Biosciences
JBIO
$693M
| $49.7M | 2.45% |
3,220,364
|
|
||
13
Enliven Therapeutics
ELVN
$1.75B
| $49.7M | 2.45% |
3,226,331
|
|
||
14
Oric Pharmaceuticals
ORIC
$1.54B
| $46.4M | 2.29% |
5,676,230
-920,655
|
|
||
15
enGene Holdings
ENGN
$581M
| $43.1M | 2.13% |
4,771,414
-275,000
|
|
||
16
Dyne Therapeutics
DYN
$2.45B
| $42.5M | 2.1% |
2,173,913
|
|
||
17
Dianthus Therapeutics
DNTH
$2.82B
| $41.2M | 2.04% |
1,000,000
+39,197
|
|
||
|
UPB
18
Upstream Bio Inc
UPB
$414M
| $31.7M | 1.57% |
1,169,298
|
|
||
|
HELP
19
Cybin Inc
HELP
$262M
| $31.4M | 1.55% |
+3,840,250
|
|
||
20
Zura Bio
ZURA
$661M
| $28M | 1.38% |
5,345,115
+713,899
|
|
||
21
Vor Biopharma
VOR
$628M
| $25.4M | 1.26% |
1,943,766
+1,443,800
|
|
||
|
CBIO
22
Crescent Biopharma
CBIO
$367M
| $25.3M | 1.25% |
2,133,576
+745,712
|
|
||
|
SEPN
23
Septerna Inc
SEPN
$1.29B
| $17M | 0.84% |
610,808
|
|
||
24
Surrozen
SRZN
$232M
| $14.3M | 0.71% |
632,931
|
|
||
25
Cullinan Oncology
CGEM
$930M
| $14.3M | 0.71% |
1,379,965
|
|